RecruitingNot ApplicableNCT07093749

Perspectives on Antibiotics and Tracking Symptoms in Children

PATSy Perspectives on Antibiotics and Tracking Symptoms in Children - a Mixed Methods Feasibility Study


Sponsor

Murdoch Childrens Research Institute

Enrollment

300 participants

Start Date

Sep 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The study will assess families' perspectives and decision-making regarding the duration of oral antibiotic courses prescribed to children (4-17 years) who present with uncomplicated bacterial infections at the Royal Children's Hospital (RCH) Emergency Department (ED). The study will involve (i) children discharged from ED on oral antibiotics and (ii) children transferred to Hospital-in-the-Home (HITH) on IV antibiotics who then switch to oral antibiotics. In addition, the study will assess how feasible and acceptable it is to track children's symptoms via the Garmin Smartwatch and the WeGuide platform (WeGuide is a patient engagement software platform that allows for enrolment, consent, and data collection \[via questionnaires/surveys and from the Garmin Smartwatches\] through a singular platform).


Eligibility

Min Age: 4 YearsMax Age: 17 Years

Inclusion Criteria4

  • Between the ages of ≥ 4 years and ≤ 17 years at enrolment.
  • Diagnosed with any of the following at RCH ED: urinary tract infection (UTI), cellulitis, impetigo, pharyngitis, tonsillitis, respiratory tract infections, otitis media.
  • Prescribed oral antibiotics (either immediately or as switch from IV antibiotics after transfer to HITH) as standard of care due to having uncomplicated infection as deemed by their treating doctor.
  • Parent/guardian provides a signed and dated informed consent form.

Exclusion Criteria1

  • \- Parent/guardian does not speak English

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEGarmin Smartwatch

Garmin Venu 3 - Worn for the duration of antibiotic course


Locations(1)

Royal Children's Hospital

Melbourne, Victoria, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07093749


Related Trials